🔎 Trials Near Me

Home › Blood Cancers › Washington › Seattle

Blood Cancers clinical trials in Seattle, WA

18 studies for Blood Cancers are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • and 1 more
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

RecruitingPhase 1/2
  • Fred Hutchinson Cancer Research Center, Seattle
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06697184

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

RecruitingObservational study
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • University of Washington, Seattle
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

RecruitingHealthy volunteers welcome
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT04515810

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

RecruitingPhase 2
  • Fred Hutchinson Cancer Center, Seattle
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT06665100

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Fred Hutchinson Cancer Research Center, Seattle
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

IVIG for Infection Prevention After CAR-T-Cell Therapy

RecruitingPhase 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05952804

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

RecruitingPhase 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Ages 18 to 75 · All sexes · Updated Jun 22, 2026 · NCT03670966

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

RecruitingObservational study
  • Seattle Childrens Hospital, Seattle
Up to age 30 · All sexes · Updated Jun 18, 2026 · NCT06579469

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RecruitingPhase 1/2
  • University of Washington Medical Center, Seattle
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

RecruitingPhase 2Healthy volunteers welcome
  • Fred Hutchinson Cancer Centre, Seattle
Ages 2 and older · All sexes · Updated Apr 16, 2026 · NCT06510699

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

RecruitingObservational study
  • Swedish Cancer Institute, Seattle
Ages 18 and older · All sexes · Updated Jun 25, 2025 · NCT05768269

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Recruiting
  • University of Washington, Seattle
Ages 18 and older · All sexes · Updated Apr 20, 2025 · NCT05956457

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

RecruitingPhase 1
  • Fred Hutchinson Cancer Center, Seattle
Ages 18 and older · All sexes · Updated Apr 15, 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Seattle Children's Hospital, Seattle
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

RecruitingPhase 1
  • Fred Hutchinson Cancer Center, Seattle
Ages 18 and older · All sexes · Updated Nov 15, 2024 · NCT06034275

Blood Cancers trials in other cities

Other studies in Seattle

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.